ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

233
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
21 Sep 2016 09:03

ANIMAL SPIRITS™ REPORT: Japan Equity Market Outlook - Escaping The Value Trap

Investment Conclusions We are currently "neutral" in our view on Japan in global developed market portfolios but "underweight" in our APAC...

Share
16 Sep 2016 07:57

Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?

The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...

13 Sep 2016 19:39

Japan Stock Market Seasonality - Late Q4 Is Indeed Good

Pelham Smithers came out with a worthwhile comment on the Q4 seasonality of Japanese markets. I agree with their assessment of being bullish Japan...

Logo
252 Views
Share
05 Sep 2016 13:45

Short Sell Research Vs The Japan Stock Market Blob

Two recent press articles "Muddy Waters and Andrew Left: the short sellers having a ball" (...

29 Aug 2016 22:03

Japan Pharma Hits 52 Week Low

The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...

x